Allan Faircloth
Nurse Practitioner · Greensboro, NCNPI 1457876591
Payments from drug & device makers
Across 350 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Alkermes, Inc.$1K
- Lundbeck LLC$820
- Otsuka America Pharmaceutical, Inc.$562
- AbbVie$489
- Indivior Inc.$342
- plus $2K from 16 others
What the payments were for
- Food & beverage$6,673100%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 71 | $1,284 |
| Alkermes, Inc. | 76 | $1,223 |
| Lundbeck LLC | 45 | $820 |
| Otsuka America Pharmaceutical, Inc. | 25 | $562 |
| AbbVie | 23 | $489 |
| Indivior Inc. | 16 | $342 |
| Neurocrine Biosciences, Inc. | 9 | $328 |
| Corium, LLC | 14 | $311 |
| Braeburn Inc. | 15 | $257 |
| Tris Pharma Inc | 11 | $192 |
| E.r. Squibb & Sons, L.L.C. | 8 | $174 |
| Supernus Pharmaceuticals, Inc. | 7 | $127 |
| Sunovion Pharmaceuticals Inc. | 7 | $122 |
| Axsome Therapeutics, Inc. | 5 | $113 |
| Vanda Pharmaceuticals Inc. | 4 | $88 |
| Neos Therapeutics, LP | 3 | $52 |
| Teva Pharmaceuticals USA, Inc. | 3 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
| Validus Pharmaceuticals LLC | 1 | $32 |
| Ironshore Pharmaceuticals Inc. | 2 | $30 |
| Lilly USA, LLC | 1 | $24 |
| Almatica Pharma LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$125
How this compares
$6,688 in reported general payments places this provider in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CaplytaLumateperone Tosylate | 32 | $64,164 |
| VraylarCariprazine Hcl | 18 | $27,421 |
| LybalviOlanzapine/Samidorphan Malate | 11 | $19,022 |
| TrintellixVortioxetine Hydrobromide | 27 | $13,330 |
| BelsomraSuvorexant | 25 | $13,208 |
| Adzenys Xr-OdtAmphetamine | 12 | $6,143 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 70 | $2,506 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 17 | $973 |
| Quetiapine Fumarate | 30 | $829 |
| Lamotrigine | 67 | $733 |
| Lithium Carbonate ErLithium Carbonate | 33 | $705 |
| Aripiprazole | 51 | $704 |
| Duloxetine Hcl | 44 | $667 |
| Clonazepam | 52 | $422 |
| Bupropion XlBupropion Hcl | 18 | $401 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,284 | $64,16432 claims |
| AbbVieVraylar | $489 | $27,42118 claims |
| Alkermes, Inc.Lybalvi | $1,223 | $19,02211 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $48 | $13,33027 claims |
| Neos Therapeutics, LPAdzenys Xr-Odt | $52 | $6,14312 claims |
| Almatica Pharma LLCSertraline Hcl | $19 | $7618 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.
Other nurse practitioner in Greensboro
- Amber SeilerGreensboro$55K
- Dawn DrazekGreensboro$18K
- Mary PrevostGreensboro$12K
- Sandrivette JohnsonRaleigh$573K
- Skyler RogersPinehurst$174K
- Jamie DinerDurham$170K
- Ayeshia WrightMocksville$145K
- Deborah AllenDurham$112K
- Jeanann VawterGastonia$97K
- Terra KampJacksonville$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.